Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with multi-organ
involvement, fibrosis and vasculopathy. Treatment in SSc, including early diffuse cutaneous …

Importance Interstitial lung disease (ILD) consists of a group of pulmonary disorders
characterized by inflammation and/or fibrosis of the lung parenchyma associated with …

Several lines of evidence suggest a role of B cells in severe systemic sclerosis (SSc)
pathophysiology: elevated levels of B-cell stimulating factors, disturbed B-cell homeostasis …

Objective We provide evidence‐based recommendations regarding the treatment of
interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases …

Background Standard of care for interstitial lung disease (ILD) with a nonspecific interstitial
pneumonia (NSIP) pattern proposes mycophenolate mofetil (MMF) as one of the first-step …

Interstitial lung disease (ILD) is a diverse group of inflammatory and fibrotic lung conditions
causing significant morbidity and mortality. A multitude of factors beyond the lungs influence …

Systemic sclerosis (SSc), or scleroderma, is a rare, complex, systemic autoimmune disease
of unknown aetiology, characterized by high morbidity and mortality often resulting from …

Immune cells have been implicated in interstitial lung diseases (ILDs), although their
phenotypes and effector mechanisms remain poorly understood. To better understand these …

Background: The American Thoracic Society convened an international, multidisciplinary
panel to develop clinical practice guidelines for the treatment of systemic sclerosis …

Interstitial lung disease in patients with anti-neutrophil c... : Current Opinion in Pulmonary
Medicine Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated …